⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14365414 | 0.82 | CTSV (0.31) | — | |
| SCHEMBL855803 | 0.81 | — | — | |
| SCHEMBL16471018 | 0.81 | — | — | |
| SCHEMBL13327528 | 0.81 | — | — | |
| SCHEMBL13094607 | 0.78 | — | — | |
| SCHEMBL5093293 | 0.78 | — | — | |
| SCHEMBL13809878 | 0.78 | — | — | |
| SCHEMBL4811947 | 0.77 | — | — | |
| SCHEMBL14344812 | 0.77 | PSEN1 (0.42) | — | |
| SCHEMBL13759960 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5576355-A | INHIBITING HUMAN T-CELL LEUKEMIA/LYMPHOMA VIRUS | MOBIL OIL CORP. (US) | 1996-11-19 | — | — | US | claimed |
| EP-0706384-A1 | DIAMONDOID DERIVATIVES FOR PHARMACEUTICAL USE | MOBIL OIL CORPORATION (US) | 1996-04-17 | — | — | EP | claimed |
| WO-1994028885-A1 | DIAMONDOID DERIVATIVES FOR PHARMACEUTICAL USE | MOBIL OIL CORPORATION (US) | 1994-12-22 | — | — | WO | claimed |
| US-5576355-A | INHIBITING HUMAN T-CELL LEUKEMIA/LYMPHOMA VIRUS | MOBIL OIL CORP. (US) | 1996-11-19 | — | — | US | disclosed |
| EP-0706384-A1 | DIAMONDOID DERIVATIVES FOR PHARMACEUTICAL USE | MOBIL OIL CORPORATION (US) | 1996-04-17 | — | — | EP | disclosed |
| WO-1994028885-A1 | DIAMONDOID DERIVATIVES FOR PHARMACEUTICAL USE | MOBIL OIL CORPORATION (US) | 1994-12-22 | — | — | WO | disclosed |